DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹15,937 Cr | ₹14,863 Cr | ₹14,619 Cr | ₹11,387 Cr | ₹9,425 Cr |
What is the latest Total Liabilities ratio of DIVIS LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹15,937 Cr |
Mar2023 | ₹14,863 Cr |
Mar2022 | ₹14,619 Cr |
Mar2021 | ₹11,387 Cr |
Mar2020 | ₹9,425 Cr |
How is Total Liabilities of DIVIS LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹15,937 Cr | 7.23 | |
Mar2023 | ₹14,863 Cr | 1.67 | |
Mar2022 | ₹14,619 Cr | 28.39 | |
Mar2021 | ₹11,387 Cr | 20.82 | |
Mar2020 | ₹9,425 Cr | - |
Compare Total Liabilities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹149,272.1 Cr | 4.1% | -7% | 52% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | 2.2% | -5.8% | 22.9% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 1.3% | -4.8% | 9.5% | Stock Analytics | |
MANKIND PHARMA | ₹102,348.0 Cr | 0.9% | -15.6% | 21.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 2.2% | -10.9% | -0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 7% | -0.2% | 27.5% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 4.1% |
-7% |
52% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses